Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study
August 2023Katie RobinsonIn patients with early relapsed multiple myeloma (MM), the addition of the anti-CD38 antibody isatuximab (Isa) to carfilzomib-dexamethasone (Kd) maintained the improved progre
Updated on: February 18,2024
9
Isa-Kd Prolongs PFS to Almost Three Years in Early Relapsed MM Follow-up Study
August 2023Katie RobinsonIn patients with early relapsed multiple myeloma (MM), the addition of the anti-CD38 antibody isatuximab (Isa) to carfilzomib-dexamethasone (Kd) maintained the improved progre
Updated on:February 18,2024
9